Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Chris W. who wrote (2671)	3/23/2000 3:03:00 PM
From: Andrew	Read Replies (1) \| Respond to of 2742

Chris and Walter: Just tell me what to do and I will do it! Cumulatively, SI subscribers probably control over 100,000 shares, and who knows how many are owned over at Raging Bull. Therefore, instructions should be posted on both the SI and RB CIST discussion sites. Whatever pressure can be applied can only have a beneficial effect.

To: Chris W. who wrote (2671)	3/29/2000 1:21:00 AM
From: Walter Morton	Respond to of 2742

CLL is getting several newly issued patents and newly filed patent applications that are licensed to CIST, but CIST decided not to mention these new intellectual properties to its shareholders until the 8-K filing on 3/28/2000. These are additional examples of CIST not sharing information about significant events in a timely manner. One could argue that IBM and Lucent Technologies don't put out a news release every month to list its new patents. However, those are well established companies. CIST is a developing company where each patent could have a significant affect on the future and stock price of this small company.

To: Chris W. who wrote (2671)	4/15/2000 2:07:00 AM
From: Walter Morton	Respond to of 2742

Has anybody heard of the New Jersey Economic Development Authority (NJEDA)? Apparently, in New Jersey, emerging technology and biotechnology companies are allowed to sale unused New Jersey net operating loss carryovers. The tax credits are based on the net operating losses for the Company and each subsidiary filing in New Jersey. The credits are calculated at a tax rate of 9% and the Company is then allowed to sell the credits for a minimum of 75% of the Tax Benefits Authorized. CIST is located in Pine Brook, NJ. I wonder if CIST ever used that tax credit?